BRCA1基因突变与乳腺癌易感性及其乳腺癌分型特征的关联分析
|
摘要
目的研究BRCA1基因特定外显子位点突变与乳腺癌发病年龄、早发性和三阴性的相关性。方法对纳入的172例散发性乳腺癌患者外周血进行DNA提取,并对患者BRCA1基因第2、10、11 3个外显子突变高频区域进行基因测序。应用统计学分析,对BRCA1基因位点突变同乳腺癌分型进行关联分析。结果 172例患者中发现15例BRCA1基因突变患者,12个突变位点,基因突变频率为8.72%。12个突变位点中2号外显子1个(162A>G),10号外显子4个(1227G>A、2238T>C、2309G>A及2798T>C),11号外显子7个(1504delTTAAA、2201C>T、2731T>C、3232A>G、3449insA、3537A>G及3667A>G)。此外,早发性乳腺癌患者BRCA1突变率7.87%,非早发性乳腺癌患者突变率2.41%,两者之间无显著性差异(χ~2=2.578,P=0.108)。BRCA1基因突变患者平均年龄(43.73±4.90)岁,显著低于无突变组(51.12±5.13岁)(P=0.021)。三阴性乳腺癌患者BRCA1突变率为14.29%,显著高于非三阴性乳腺癌患者的5.50%突变率,两者之间存在统计学差异(χ~2=3.867,P=0.049)。结论 BRCA1基因突变患者年龄低,且基因突变与三阴性乳腺癌相关。
Objective To study the correlation among the mutation of BRCA1 gene specific exon sites and age of onset,early-onset breast cancer,and triple-negative breast cancer.Methods DNA was extracted from peripheral blood of 172 patients with sporadic breast cancer and the genes were sequenced in the high frequency regions of 2,10 and 11 of BRCA1 gene.Statistical analysis was used to analyze the association of BRCA1 gene mutation with breast cancer typing.Results In this study,15 cases of BRCA1 mutations with 12 mutation sites were found,and the frequency of BRCA1 mutation was 8.72%.There were one mutation in exon 2(162 A>G),four mutations in exon 10(1227 G>A、2238T>C、2309 G>A and 2798 T>C),and seven mutations in exon 11(1504 del TTAAA、2201 C>T、2731T>C、3232 A>G、3449 ins A、3537 A>G and 3667 A>G).In addition,the rate of BRCA1 mutation in early-onset breast cancer was 7.87%,and the mutation rate was 2.41%in non-early-onset breast cancer patients.There was no significant difference between the two groups(χ~2=2.578,P=0.108).The mean age of BRCA1 mutations was(43.73±4.90)years,which was lower significantly than that of the non-mutant group(51.12±5.13)(P=0.021).14.29% of BRCA1 mutant group were diagnosed as triple-negative breast cancer,and the diagnostic rate of BRCA1 nonmutant group was 5.50%,and there was significant difference between the two groups(χ~2=3.867,P=0.049).Conclusion Triple-negative breast cancer arising in young people was correlated with BRCA1 gene mutation.
Objective To study the correlation among the mutation of BRCA1 gene specific exon sites and age of onset,early-onset breast cancer,and triple-negative breast cancer.Methods DNA was extracted from peripheral blood of 172 patients with sporadic breast cancer and the genes were sequenced in the high frequency regions of 2,10 and 11 of BRCA1 gene.Statistical analysis was used to analyze the association of BRCA1 gene mutation with breast cancer typing.Results In this study,15 cases of BRCA1 mutations with 12 mutation sites were found,and the frequency of BRCA1 mutation was 8.72%.There were one mutation in exon 2(162 A>G),four mutations in exon 10(1227 G>A、2238T>C、2309 G>A and 2798 T>C),and seven mutations in exon 11(1504 del TTAAA、2201 C>T、2731T>C、3232 A>G、3449 ins A、3537 A>G and 3667 A>G).In addition,the rate of BRCA1 mutation in early-onset breast cancer was 7.87%,and the mutation rate was 2.41%in non-early-onset breast cancer patients.There was no significant difference between the two groups(χ~2=2.578,P=0.108).The mean age of BRCA1 mutations was(43.73±4.90)years,which was lower significantly than that of the non-mutant group(51.12±5.13)(P=0.021).14.29% of BRCA1 mutant group were diagnosed as triple-negative breast cancer,and the diagnostic rate of BRCA1 nonmutant group was 5.50%,and there was significant difference between the two groups(χ~2=3.867,P=0.049).Conclusion Triple-negative breast cancer arising in young people was correlated with BRCA1 gene mutation.
引文
[1]尹红英,王红兵.耐紫杉醇人肺腺癌A549细胞株中BRCA1基因启动子Cp G岛甲基化的研究[J].实用癌症杂志,2012,27(4):337-338.
[2]杨晓晨,胡震.BRCA1和BRCA2基因外显率研究概况[J].中华临床医师杂志:电子版,2013,7(3):136-137.
[3]严梅娣,王琳,李国庆,等.宁波地区乳腺癌BRCA1基因突变检测的研究[J].中国医药科学,2016,6(24):198-200.
[4]朱安娜.BRCA1-2突变与中国汉族女性乳腺癌发病关系及中外显性遗传多态性与其关联性研究[D].南方医科大学,2015.
[5]付欣鸽,王振华,李锋,等.110例维吾尔族及汉族乳腺癌中BRCA1基因突变及P53蛋白表达的研究[J].中国组织化学与细胞化学杂志,2007,16(3):340-346.
[6]刘军杰,陈圆圆,李智贤,等.广西地区散发性乳腺癌BRCA1突变及其相关临床、组织病理特征的研究[J].广西医科大学学报,2013,30(4):496-499.
[7]查国松,左文述.BRCA1与乳腺癌的研究进展[J].中国普外基础与临床杂志,2017,24(7):900-904.
[8]De J,Esteban CE,Palanca SS,et al.Low prevalence of B-RCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population[J].Familial Cancer,2012,11(1):49-56.
[9]Al-Moghrabi N,Nofel A,Al-Yousef N,et al.The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females[J].BMC Cancer,2014,14(1):830.
[10]Sun J,Meng H,Yao L,et al.Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients[J].Clinical Cancer Research,2017,23(20):6113-6119.
[11]Riahi A,Kharrat M,Ghourabi ME,et al.Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia[J].Clin Gen,2015,87(2):155-160.
[12]宋传贵,胡震,袁文涛,等.上海地区早发性乳腺癌患者BRCA1和BRCA2基因突变分析[J].中华医学杂志,2005,85(43):3030-3034.
[13]Turchetti D,Cortesi L,Federico M,et al.BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer[J].Euro J Cancer,2000,36(16):2083-2089.
[14]Shastry M,Yardley DA.Updates in the treatment of basal/triple-negative breast cancer[J].Curr Oncol,2013,25(1):40-48.
[15]刘桂超,邬蒙.三阴乳腺癌的研究进展[J].实用癌症杂志,2010,25(1):239-242.
[16]曹路路,孙子家,管晓翔.BRCA1/2突变型乳腺癌的治疗策略[J].癌症进展,2015,13(5):466-470.
[2]杨晓晨,胡震.BRCA1和BRCA2基因外显率研究概况[J].中华临床医师杂志:电子版,2013,7(3):136-137.
[3]严梅娣,王琳,李国庆,等.宁波地区乳腺癌BRCA1基因突变检测的研究[J].中国医药科学,2016,6(24):198-200.
[4]朱安娜.BRCA1-2突变与中国汉族女性乳腺癌发病关系及中外显性遗传多态性与其关联性研究[D].南方医科大学,2015.
[5]付欣鸽,王振华,李锋,等.110例维吾尔族及汉族乳腺癌中BRCA1基因突变及P53蛋白表达的研究[J].中国组织化学与细胞化学杂志,2007,16(3):340-346.
[6]刘军杰,陈圆圆,李智贤,等.广西地区散发性乳腺癌BRCA1突变及其相关临床、组织病理特征的研究[J].广西医科大学学报,2013,30(4):496-499.
[7]查国松,左文述.BRCA1与乳腺癌的研究进展[J].中国普外基础与临床杂志,2017,24(7):900-904.
[8]De J,Esteban CE,Palanca SS,et al.Low prevalence of B-RCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population[J].Familial Cancer,2012,11(1):49-56.
[9]Al-Moghrabi N,Nofel A,Al-Yousef N,et al.The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females[J].BMC Cancer,2014,14(1):830.
[10]Sun J,Meng H,Yao L,et al.Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients[J].Clinical Cancer Research,2017,23(20):6113-6119.
[11]Riahi A,Kharrat M,Ghourabi ME,et al.Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia[J].Clin Gen,2015,87(2):155-160.
[12]宋传贵,胡震,袁文涛,等.上海地区早发性乳腺癌患者BRCA1和BRCA2基因突变分析[J].中华医学杂志,2005,85(43):3030-3034.
[13]Turchetti D,Cortesi L,Federico M,et al.BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer[J].Euro J Cancer,2000,36(16):2083-2089.
[14]Shastry M,Yardley DA.Updates in the treatment of basal/triple-negative breast cancer[J].Curr Oncol,2013,25(1):40-48.
[15]刘桂超,邬蒙.三阴乳腺癌的研究进展[J].实用癌症杂志,2010,25(1):239-242.
[16]曹路路,孙子家,管晓翔.BRCA1/2突变型乳腺癌的治疗策略[J].癌症进展,2015,13(5):466-470.